Searchable abstracts of presentations at key conferences in endocrinology

ea0016s26.3 | New therapeutic options in diabetes | ECE2008

Emerging therapeutic approaches to preserve beta cell function in type 1 DM

Chatenoud Lucienne

Antibodies to CD3 are potent immunosuppressants now applied as non Fc-receptor (FcR) binding monoclonals.Data from our laboratory demonstrated that in NOD mice CD3 antibodies could reverse recent onset disease by restoring tolerance to beta cell antigens in a durable fashion. Thus in mice presenting full-blown diabetes, a five consecutive day treatment with low doses of the hamster anti-CD3 monoclonal antibody 145 2C11 or its F(ab)′2 fragments indu...